This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Wed Jun 19, 2013 2:11 pm


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 1 post ] 
Author Message
PostPosted: Wed Mar 28, 2012 12:33 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1711
Alemtuzumab more effective than interferon β-1a at 5-year follow-up

Image

Summary: The authors present 5-year follow-up data from the CAMMS223 study, reporting on the long-term safety and efficacy of alemtuzumab treatment compared with interferon β-1a in early, active relapsing-remitting multiple sclerosis (RRMS). Over 5 years, alemtuzumab lowered the risk of sustained accumulation of disability by 72%. The annualised relapse rate over the 5 years was 0.11 for alemtuzumab and 0.35 for IFNβ-1a.

Most commonly occurring serious side effects were serious infections occurring in 7% of alemtuzumab treated patients, with 30% developing thyroid problems (compared to only 4% in IFNβ-1a group).

The study shows good evidence for the efficacy in reducing progression of disability and relapse rate reduction in patients with RRMS compared with IFNβ-1a and side effect profile in line with previously published data....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1307

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 1 post ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Genzyme MS Drug Effective After Five Years .

scorpion

0

1383

Thu Oct 14, 2010 9:29 am

scorpion View the latest post

There are no new unread posts for this topic. Spotlight on Alemtuzumab

Waterbear

2

2006

Mon Mar 08, 2010 5:57 pm

leetz View the latest post

There are no new unread posts for this topic. Autoimmune disease after alemtuzumab treatment for MS

squiffy2

0

1390

Wed Sep 14, 2011 3:42 am

squiffy2 View the latest post

There are no new unread posts for this topic. Approval sought for Lemtrada(TM) (alemtuzumab) for MS

squiffy2

0

788

Tue Jun 12, 2012 2:09 am

squiffy2 View the latest post

There are no new unread posts for this topic. New data from Alemtuzumab phase 2 MS trial released

squiffy2

0

1253

Sun Apr 10, 2011 4:12 am

squiffy2 View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to:  


News News Site map Site map SitemapIndex SitemapIndex RSS Feed RSS Feed Channel list Channel list
Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!


Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers

Advertise on the premier multiple sclerosis forum